Cera has acquired robot technology platform GenieConnect and will scale home care robots after pilots.
Earlier this year, Cera piloted droid-like robots driven by AI in patients’ homes, which it said carried out 3,000 visits a week to elderly and vulnerable people.
It has secured a deal with the robots’ manufacturer, allowing faster adoption of robots across home care.
GenieConnect’s robots give food, drink and medication reminders, check mood and wellbeing, and keep people connected to care teams and loved ones.
Pilots delivered a 96 per cent success rate for on-time medication, 64 to 80 per cent success encouraging people to eat, and 78 to 90 per cent success encouraging regular drinking.
“At Cera, we believe that virtual care, AI and robotics have a key role to play in the future of this sector – allowing more people to be sustainably cared for, as the population ages and demand for care grows.” said Dr Ben Maruthappu, founder and chief executive of Cera.
“GenieConnect has performed well with our patients this year, and we’re excited to take this platform to the next level, expanding access to high-quality, preventative care, and transforming lives across the country.”
The robots have been trialled by more than 12 local councils and 30 care providers. Cera plans a wider rollout across its own services and will license the technology across the sector.
The company expects to scale them across several new regions and more care providers over the next 18 months.
Cera also plans to integrate GenieConnect’s software with its own technology and dataset, training the robots with preventative AI tools to improve prevention, care quality and outcomes for older and vulnerable people.
By licensing the robots to other care providers, Cera aims to scale the impact of its preventative technology across the sector and add a new revenue stream.
Cera says the acquisition follows a transaction of more than US$150m (£123m) in January 2025 to scale its AI-led home healthcare technology.
